chr7-143052470-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001001667.1(OR6V1):āc.130A>Gā(p.Ile44Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000297 in 1,613,752 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001001667.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR6V1 | NM_001001667.1 | c.130A>G | p.Ile44Val | missense_variant | 1/1 | ENST00000418316.2 | NP_001001667.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR6V1 | ENST00000418316.2 | c.130A>G | p.Ile44Val | missense_variant | 1/1 | NM_001001667.1 | ENSP00000396085 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152054Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000157 AC: 39AN: 249184Hom.: 0 AF XY: 0.0000962 AC XY: 13AN XY: 135184
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461698Hom.: 0 Cov.: 33 AF XY: 0.0000220 AC XY: 16AN XY: 727134
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152054Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74260
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2022 | The c.130A>G (p.I44V) alteration is located in exon 1 (coding exon 1) of the OR6V1 gene. This alteration results from a A to G substitution at nucleotide position 130, causing the isoleucine (I) at amino acid position 44 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at